HCV trial successfully concluded showing drug to be safe and effective. "100% of HCV trial patients receiving 400mg of BIT225 daily for 1 month, had undetectable virus the at 48 week time point"
New batch of BIT225 successfully manufactured with new formulation delivered in capsulated form to make future trials easier and a key milestone necessary for commercialisation.
HIV trial successfully completed. Analysis of results expected to be announced in the next 24 hours. Early trial results show that the drug is effective against HIV. Detailed analysis will tell us exactly how much so.
HIV / HCV coinfected trial underway
Doesn't sound like much but there is a shoot load of work completed and more importantly, trial results so far have been very possitive, ie no safety problems, no failures. The drug works against both HCV and HIV viruses. We still need to find out exactly how well it works against HIV but to say nothing has happened is disingenuous at the very least.
While I have no porblem with people coming here and providing factual and unadulterated information, it appears that the sole purpose of your post is to insult those that have the gumption to invest in a good idea and the conviction to stick with it through the long hard road to possible future commercialisation. I guess in respect to lack of willingness to contribute something useful, nuthin has changed since your last post, aye rmp ?
BIT Price at posting:
8.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)